The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer
Abstract
Enhanced glucose and lipid metabolism is one of the most common properties of malignant cells. ATP citrate lyase (ACLY) is a key enzyme of de novo fatty acid synthesis responsible for generating cytosolic acetyl-CoA and oxaloacetate. To evaluate its role in lung cancer progression, we here analyzed ACLY expression in a subset of human lung adenocarcinoma cell lines and showed a relationship with the phosphatidyl-inositol-3 kinase–Akt pathway. The introduction of constitutively active Akt into cells enhanced the phosphorylation of ACLY, whereas dominant-negative Akt caused attenuation. In human lung adenocarcinoma samples, ACLY activity was found to be significantly higher than in normal lung tissue. Immunohistochemical analysis further showed phosphorylated ACLY overexpression in 162 tumors, well-correlating with stage, differentiation grade, and a poorer prognosis. Finally, to show the therapeutic potential and mechanism of ACLY inhibition for lung cancer treatment, we assessed the effect of RNA interference targeting ACLY on lipogenesis and cell proliferation in A549 cells. ACLY inhibition resulted in growth arrest in vitro and in vivo. Interestingly, increased intracellular lipids were found in ACLY knockdown cells, whereas de novo lipogenesis was inhibited. Supplementation of insulin could rescue the proliferative arrest elicited by ACLY inhibition; however, in contrast, fatty acid palmitate induced cell death. Taken together, these findings suggest that ACLY is involved in lung cancer pathogenesis associated with metabolic abnormality and might offer a novel therapeutic target. [Cancer Res 2008;68(20):8547–54]
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ACLY activity is elevated in cancers (Migita et al., 2008), and targeting ACLY genetically or chemically prevents xenograft tumor formation and proliferation (Adam et al., 2013; Bauer et al., 2005; Hatzivassiliou et al., 2005; Migita et al., 2008).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Migita et al., 2008
In the citing paper
“In fact, all three major components involved in fatty acyl chain biosynthesis – ACLY, ACC and FASN – are frequently upregulated in transformed cells; furthermore, their inhibition reduces tumor cell growth in vitro and in vivo (Chajes et al., 2006; Flavin et al., 2010; Migita et al., 2008; Milgraum et al., 1997).”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Migita et al., 2008
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
AKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941
PI3K/Akt signalling pathway and cancer
Vara, J. Á. F., Casado, E., de Castro, J., Cejas, P., Belda-Iniesta, C., & González-Barón, M. (2003) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2003.07.007 · Cited by 2,489
Glycolysis inhibition for anticancer treatment
Pelicano, H., Martin, D. S., Xu, R., & Huang, P. (2006) · Oncogene · doi:10.1038/sj.onc.1209597 · Cited by 1,546
Histological Typing of Lung and Pleural Tumours
Travis, W. D., Colby, T. V., CORRIN, B., Shimosato, Y., & Brambilla, E. M. (1999) · Springer eBooks · doi:10.1007/978-3-642-60049-4 · Cited by 1,534
Akt Stimulates Aerobic Glycolysis in Cancer Cells
Elstrom, R. L., Bauer, D. E., Buzzai, M., Karnauskas, R., Harris, M. H., Plas, D. R., Zhuang, H., Cinalli, R. M., Alavi, A., Rudin, C. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2904 · Cited by 1,454
Large-scale characterization of HeLa cell nuclear phosphoproteins
Beausoleil, S. A., Jedrychowski, M. P., Schwartz, D., Elias, J. E., Villén, J., Li, J., Cohn, M. A., Cantley, L. C., & Gygi, S. P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404720101 · Cited by 1,376
Cited by
Sorted by citations
Items 201–300 of 404
Role of Lipogenesis Rewiring in Hepatocellular Carcinoma
Zhou, Y., Tao, J., Calvisi, D. F., & Chen, X. (2021) · Seminars in Liver Disease · doi:10.1055/s-0041-1731709 · Cited by 30
Deregulated Metabolic Pathways in Ovarian Cancer: Cause and Consequence
Murali, R., Balasubramaniam, V., Srinivas, S., Sundaram, S., Venkatraman, G., Warrier, S. R., Dharmarajan, A., & Gandhirajan, R. K. (2023) · Metabolites · doi:10.3390/metabo13040560 · Cited by 34
Guerram, M., Jiang, Z., Yousef, B. A., Hamdi, A. M., Hassan, H. M., Yuan, Z., Luo, H.-W., Zhu, X., & Zhang, L. (2015) · Oncotarget · doi:10.18632/oncotarget.4156 · Cited by 31
Dashatan, N. A., Koushki, M., Jalilian, A., Ahmadi, N., & Rezaei–Tavirani, M. (2020) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2020.21.6.1841 · Cited by 30
Dual role of pseudogene TMEM198B in promoting lipid metabolism and immune escape of glioma cells
Zhan, Y., Qiao, W., Yi, B., Yang, X., Li, M., Sun, L., Ji, L., Su, P., Wang, X., Zhang, F., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02445-0 · Cited by 30
Shen, T., Wang, H., Tang, B., Zhu, G., & Wang, X. (2023) · RNA Biology · doi:10.1080/15476286.2023.2216562 · Cited by 29
Lipid metabolism dynamics in cancer stem cells: potential targets for cancers
Du, J., & Qin, H. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1367981 · Cited by 31
Protein Acetylation at the Interface of Genetics, Epigenetics and Environment in Cancer
Harachi, M., Masui, K., Cavenee, W. K., Mischel, P. S., & Shibata, N. (2021) · Metabolites · doi:10.3390/metabo11040216 · Cited by 29
Associations among Metabolism, Circadian Rhythm and Age-Associated Diseases
Cao, Y., & Wang, R.-H. (2017) · Aging and Disease · doi:10.14336/ad.2016.1101 · Cited by 28
Báez, R. V. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.73796 · Cited by 27
Tan, J., Che, Y., Liu, Y., Hu, J., Wang, W., Hu, L., Zhou, Q., Wang, H., & Li, J. (2021) · The FASEB Journal · doi:10.1096/fj.202100786rr · Cited by 28
Nutritional Epigenetics in Cancer
Barrero, M. J., Cejas, P., Long, H. W., & de Molina, A. R. (2022) · Advances in Nutrition · doi:10.1093/advances/nmac039 · Cited by 27
Fernandez-Fuente, G., Rigby, M. J., & Puglielli, L. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101653 · Cited by 30
The peculiarities of cancer cell metabolism: A route to metastasization and a target for therapy
Carvalho, T. M. A., Cardoso, H. J., Figueira, M. I., Vaz, C. V., & Socorro, S. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.03.053 · Cited by 27
Lipid metabolism reprogramming in head and neck cancer
Liang, J., Lin, L., Li, L., Zhou, X., Zhang, Z., Huang, Y., & Xiao, X. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1271505 · Cited by 26
Osinalde, N., Aloria, K., Ibarra, M. J. O., & Kratchmarova, I. (2017) · Journal of Chromatography B · doi:10.1016/j.jchromb.2017.04.026 · Cited by 27
Cancer cell lipid class homeostasis is altered under nutrient-deprivation but stable under hypoxia
Lisec, J., Jaeger, C., Rashid, R., Munir, R., & Zaidi, N. (2019) · BMC Cancer · doi:10.1186/s12885-019-5733-y · Cited by 27
Metabolic reprogramming in lung cancer and its clinical implication
Huang, Q., Fan, L., Gong, M., Ren, J. T., Chen, C., & Xie, S. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1516650 · Cited by 29
Clementino, M., Xie, J., Yang, P., Li, Y., Lin, H.-P., Fenske, W., Tao, H., Kondo, K., Yang, C., & Wang, Z. (2020) · Toxicological Sciences · doi:10.1093/toxsci/kfaa086 · Cited by 25
Cífková, E., Brumarová, R., Ovčačíková, M., Dobešová, D., Mičová, K., Kvasnička, A., Vaňková, Z., Šiller, J., Sákra, L., Friedecký, D., et al. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.159082 · Cited by 25
Minić, Z., Hüttmann, N., Poolsup, S., Li, Y., Susevski, V., Zaripov, E. A., & Berezovski, M. V. (2022) · Biomedicines · doi:10.3390/biomedicines10020408 · Cited by 25
Crosstalk between lipid metabolism and EMT: emerging mechanisms and cancer therapy
Din, Z. U., Cui, B., Wang, C., Zhang, X., Mehmood, A., Peng, F., & Liu, Q. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-04995-1 · Cited by 26
Lipid metabolic reprogramming by hypoxia-inducible factor-1 in the hypoxic tumour microenvironment
Seo, J., Yun, J.-E., Kim, S. J., & Chun, Y. (2022) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-022-02683-x · Cited by 24
Roles of posttranslational modifications in lipid metabolism and cancer progression
Feng, T., Zhang, H., Zhou, Y., Zhu, Y., Shi, S., Li, K., Lin, P., & Chen, J. (2024) · Biomarker Research · doi:10.1186/s40364-024-00681-y · Cited by 23
Targeting Cancer Metabolism and Current Anti-Cancer Drugs
Sukjoi, W., Ngamkham, J., Attwood, P. V., & Jitrapakdee, S. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-55035-6_2 · Cited by 23
Connections between metabolism and epigenetic modifications in cancer
Wang, G., & Han, J. J. (2021) · Medical Review · doi:10.1515/mr-2021-0015 · Cited by 27
A Systematic Role of Metabolomics, Metabolic Pathways, and Chemical Metabolism in Lung Cancer
Kannampuzha, S., Mukherjee, A. G., Wanjari, U. R., Gopalakrishnan, A. V., Murali, R., Namachivayam, A., Renu, K., Dey, A., Vellingiri, B., Madhyastha, H., et al. (2023) · Vaccines · doi:10.3390/vaccines11020381 · Cited by 24
Profiling Y561-Dependent and -Independent Substrates of CSF-1R in Epithelial Cells
Knowlton, M. L., Selfors, L., Wrobel, C. N., Gu, T., Ballif, B., Gygi, S., Polakiewicz, R., & Brugge, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013587 · Cited by 24
Chemical genetics in tumor lipogenesis
Braig, S. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.02.007 · Cited by 23
SIRT2‐mediated deacetylation of ACLY promotes the progression of oesophageal squamous cell carcinoma
Zhang, X., Xu, Y., Li, S., Qin, Y., Zhu, G., Zhang, Q. H., Zhang, Y.-T. Y., Guan, F., Fan, T., & Liu, H. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18129 · Cited by 21
Diacylglycerol Kinase Delta Promotes Lipogenesis
Shulga, Y. V., Loukov, D., Ivanova, P. T., Milne, S. B., Myers, D. S., Hatch, G. M., Umeh, G., Jalan, D., Fullerton, M. D., Steinberg, G. R., et al. (2013) · Biochemistry · doi:10.1021/bi401178y · Cited by 22
Beloueche‐Babari, M., Workman, P., & Leach, M. O. (2011) · Cell Cycle · doi:10.4161/cc.10.17.17192 · Cited by 22
Acetylation control of metabolic enzymes in cancer: an updated version
Huang, W., Wang, Z., & Lei, Q. (2014) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt154 · Cited by 23
Santarsiero, A., Convertini, P., Vassallo, A., Santoro, V., Todisco, S., Iacobazzi, D., Fondufe‐Mittendorf, Y. N., Martelli, G., de Oliveira, M. R., Montanaro, R., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5533793 · Cited by 22
Metabolic Remodelling: An Accomplice for New Therapeutic Strategies to Fight Lung Cancer
Mendes, C., & Serpa, J. (2019) · Antioxidants · doi:10.3390/antiox8120603 · Cited by 21
Li, Y., Zhao, J., Chen, R., Chen, S., Xu, Y., & Cai, W. (2021) · BMC Cancer · doi:10.1186/s12885-022-10017-4 · Cited by 21
Liu, D., Dong, C., Wang, F., Liu, W., Jin, X., Qi, S., Liu, L., Jin, Q., Wang, S., Jia Rui, W. U., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154732 · Cited by 22
Oncogenic MORC2 in cancer development and beyond
Zhang, S., Guo, A., Wang, H., Liu, J., Dong, C., Ren, J., & Wang, G. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.05.010 · Cited by 20
Is Acetylation a Metabolic Rheostat that Regulates Skeletal Muscle Insulin Action?
LaBarge, S. A., Migdal, C., & Schenk, S. (2015) · Molecules and Cells · doi:10.14348/molcells.2015.0020 · Cited by 21
Grunert, T., Leitner, N. R., Marchetti‐Deschmann, M., Miller, I., Wallner, B., Radwan, M., Vogl, C., Kolbe, T., Kratky, D., Gemeiner, M., et al. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.07.006 · Cited by 22
Metabolic manipulation of the tumour immune microenvironment
Wan, M., Ding, Y., Li, Z., Wang, X., & Xu, M. (2021) · Immunology · doi:10.1111/imm.13444 · Cited by 21
The metabolic switch and its regulation in cancer cells
Zhou, S., Huang, C., & Wei, Y. (2010) · Science China Life Sciences · doi:10.1007/s11427-010-4041-1 · Cited by 21
Čuperlović‐Culf, M., Culf, A. S., Touaibia, M., & Lefort, N. (2012) · Future Oncology · doi:10.2217/fon.12.121 · Cited by 21
Metabolism and cancer: an up-to-date review of a mutual connection.
Mentis, A. A., & Kararizou, E. G. (2010) · PubMed · Cited by 20
Sola‐García, A., Cáliz‐Molina, M. Á., Espadas, I., Petr, M. A., Panadero‐Morón, C., González-Morán, D., Martín-Vázquez, M. E., Narbona‐Pérez, Á. J., López–Noriega, L., Martínez-Corrales, G., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-04625-4 · Cited by 21
Qian, J., Chen, Y., Meng, T., Ma, L., Meng, L., Wang, X., Yu, T., Zask, A., Shen, J., & Yu, K. (2016) · Oncotarget · doi:10.18632/oncotarget.11490 · Cited by 19
Estimating a non-homogeneous Gompertz process with jumps as model of tumor dynamics
Giorno, V., Román‐Román, P., Spina, S., & Torres‐Ruiz, F. (2016) · Computational Statistics & Data Analysis · doi:10.1016/j.csda.2016.10.005 · Cited by 19
Xie, H., Wang, W., Sun, F., Deng, K., Lu, X. L., Liu, H., Zhao, W., Zhang, Y., Zhou, X., Li, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10559-9 · Cited by 20
Jin, X., Zhang, K., Guo, X., Myers, R. E., Ye, Z., Zhang, Z., Li, X., Yang, H., & Xing, J. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.17.7097 · Cited by 19
Mammalian SWI/SNF Enzymes and the Epigenetics of Tumor Cell Metabolic Reprogramming
Nickerson, J. A., Wu, Q., & Imbalzano, A. N. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00049 · Cited by 18
Orchestral role of lipid metabolic reprogramming in T-cell malignancy
Mehta, A., Ratre, Y. K., Soni, V. K., Shukla, D., Sonkar, S. C., Kumar, A., & Vishvakarma, N. K. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1122789 · Cited by 18
Tomar, M. S., Kumar, A., & Shrivastava, A. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.149382 · Cited by 20
Dietary lipids and adipocytes: potential therapeutic targets in cancers
Kwan, H. Y., Chao, X., Su, T., Fu, X., Liu, B., Tse, A. K., Fong, W. F., & Yu, Z. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.11.001 · Cited by 18
Beyond the Mevalonate Pathway: Control of Post-Prenylation Processing by Mutant p53
Etichetti, C. M. B., Zalazar, E. A., Cocordano, N., & Girardini, J. E. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.595034 · Cited by 17
Lipid Metabolism in Cancer Cells
Zheng, M., Wang, W., Liu, J., Zhang, X., & Zhang, R. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-33-6785-2_4 · Cited by 19
Balakrishnan, K., & Ganesan, K. (2020) · Functional & Integrative Genomics · doi:10.1007/s10142-020-00753-w · Cited by 17
Adhikari, S., Guha, D., Mohan, C., Mukherjee, S., Tyler, J. K., & Das, C. (2022) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-07634-3_1 · Cited by 19
Tan, W., Zhong, Z., Wang, S., Suo, Z., Yang, X. Q., Hu, X., & Wang, Y. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/396035 · Cited by 17
Non-canonical roles for metabolic enzymes and intermediates in malignant progression and metastasis
Williams, D., & Fingleton, B. (2019) · Clinical & Experimental Metastasis · doi:10.1007/s10585-019-09967-0 · Cited by 16
Roles of microRNA in prostate cancer cell metabolism
Kasomva, K., Sen, A., Paulraj, M. G., Sailo, S. L., Raphael, V., Puro, K.-U., Assumi, S. R., & Savarimuthu Ignacimuthu, S. J. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.07.003 · Cited by 17
Bhowmick, R., Campit, S., Katkam, S. K., Keshamouni, V. G., & Chandrasekaran, S. (2024) · Communications Biology · doi:10.1038/s42003-024-07408-7 · Cited by 17
Fatty acid metabolism and prospects for targeted therapy of cancer
Chen, T., & Li, H. (2017) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.201600366 · Cited by 16
ARHGEF3 regulates the stability of ACLY to promote the proliferation of lung cancer
Zhou, F., Ai, W., Zhang, Y., Hu, Q., Gan, M., Wang, J., & Han, T. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05297-4 · Cited by 18
Spina, S., Giorno, V., Román‐Román, P., & Torres‐Ruiz, F. (2014) · Bulletin of Mathematical Biology · doi:10.1007/s11538-014-0026-8 · Cited by 16
Zong, H., Zhang, Y., You, Y., Cai, T., & Wang, Y. (2015) · Medical Oncology · doi:10.1007/s12032-015-0540-z · Cited by 16
RetractedLiu, J., Wang, Y., Tian, M., Xia, M., Zheng, Y., Hao, M., Qian, Y., Shu, H., Zhang, W., Peng, P., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2402674121 · Cited by 15
Li, R., Li, Y., Song, Z., Gu, Y., Jiao, X., Wan, C., Liu, T., Zhang, R., Gao, R., & Wang, X. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s478308 · Cited by 15
Xie, S., Zhou, F., Wang, J., Cao, H., Chen, Y., Liu, X., Zhang, Z., Dai, J., & He, X. (2015) · World Journal of Surgical Oncology · doi:10.1186/s12957-015-0440-x · Cited by 15
Zhu, Y., Li, Y., Bai, B., Shang, C., Fang, J., Cong, J., Li, W., Li, S., Song, G., Liu, Z., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.614082 · Cited by 14
Jha, V., Galati, S., Volpi, V., Ciccone, L., Minutolo, F., Rizzolio, F., Granchi, C., Poli, G., & Tuccinardi, T. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1773314 · Cited by 13
Barpanda, A., Biswas, D., Verma, A., Parihari, S., Singh, A. K., Kapoor, S., Kantharia, C. V., & Srivastava, S. (2023) · Journal of Proteome Research · doi:10.1021/acs.jproteome.2c00646 · Cited by 12
Signalling mechanisms regulating phenotypic changes in breast cancer cells
Volinsky, N., McCarthy, C., von Kriegsheim, A., Šaban, N., Okada, M., Kölch, W., & Kholodenko, B. Ν. (2015) · Bioscience Reports · doi:10.1042/bsr20140172 · Cited by 13
Metabolic Phenotypes, Dependencies, and Adaptation in Lung CancerPreprint
DeNicola, G. M., & Shackelford, D. B. (2021) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a037838 · Cited by 13
Puertas-Umbert, L., Alonso, J., Blanco-Casoliva, L., Almendra‐Pegueros, R., Camacho, M., Rodríguez‐Sinovas, A., Galán, M., Roglans, N., Laguna, J. C., Martínez‐González, J., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.117876 · Cited by 12
Lim, J. Y., & Kwan, H. Y. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.80788 · Cited by 12
Tajima, A., Murai, N., Murakami, Y., Iwamoto, T., Migita, T., & Matsufuji, S. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.02.084 · Cited by 12
Self-citationPant, A., Belhaouari, D. B., Dsouza, L., & Yang, Z. (2024) · Journal of Virology · doi:10.1128/jvi.01103-24 · Cited by 15
Metabolic convergence on lipogenesis in RAS, BCR-ABL, and MYC-driven lymphoid malignancies
Liefwalker, D. F., Gabay, M., Wang, Z., Pathak, K. V., Plaisier, S. B., Shah, V. M., Babra, B., Dewson, G. S., Lai, I. K., Mosley, A. R., et al. (2021) · Cancer & Metabolism · doi:10.1186/s40170-021-00263-8 · Cited by 12
Non-coding RNAs derailed: The many influences on the fatty acid reprogramming of cancer
Yu, X., Wang, H., Wu, J., Wang, S., Ya-jie Tang, A., Tang, Y., & Liang, X.-H. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.05.065 · Cited by 11
Alabiad, M. A., Harb, O. A., Abozaid, M., Embaby, A., Mandour, D. A., Hemeda, R., & Shalaby, A. M. (2021) · Iranian journal of pathology · doi:10.30699/ijp.2020.130944.2452 · Cited by 11
Zhen, L., Min, M., Mo, X., Zhao, G., Li, H., Liu, M., Wan, L., Yang, X., Huang, L., Zhang, Y., et al. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.07.003 · Cited by 10
Artesunate-binding FABP5 promotes apoptosis in lung cancer cells via the PPARγ-SCD pathway
Wang, Q., Zhou, J., Cheng, A., Liu, Y., Guo, J., Li, X., Chen, M., Hu, D., & Wu, J. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113381 · Cited by 10
Acetyl-CoA synthesis in the skin is a key determinant of systemic lipid homeostasis
Nguyen, P. T., Shiue, M., Kuprasertkul, N., Costa‐Pinheiro, P., Izzo, L., Pinheiro, L. V., Affronti, H. C., Gugiu, G. B., Ghaisas, S., Liu, J. Y., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115284 · Cited by 12
Bavli, D., Sun, X., Kozulin, C., Ennis, D., Motzik, A., Biran, A., Brielle, S., Alajem, A., Meshorer, E., Buxboim, A., et al. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.04.026 · Cited by 10
PEG3 controls lipogenesis through ACLY
Ghimire, S., & Kim, J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252354 · Cited by 10
Galli, G., Corsetto, P. A., Proto, C., Russo, G. L., Ganzinelli, M., Rulli, E., Legramandi, L., Morelli, D., Ferrara, R., Prelaj, A., et al. (2022) · Clinical Lung Cancer · doi:10.1016/j.cllc.2022.07.010 · Cited by 10
Metabolic Pathways in Breast Cancer Reprograming: An Insight to Non-Coding RNAs
Gaballu, F. A., Kazemi, E. K., Salehzadeh, S. A., Mansoori, B., Eslami, F., Emami, A., Dehghan, G., Baradaran, B., Baradaran, B., & Cho, W. C. S. (2022) · Cells · doi:10.3390/cells11192973 · Cited by 11
Lipid Metabolism, Metabolic Syndrome, and Cancer
Hu, F., Zhang, Y., & Song, Y. (2013) · InTech eBooks · doi:10.5772/51821 · Cited by 11
Treue, D., Bockmayr, M. L., Stenzinger, A., Heim, D., Hester, S. S., & Klauschen, F. (2018) · International Journal of Cancer · doi:10.1002/ijc.31845 · Cited by 10
The Metabolic Remodelling in Lung Cancer and Its Putative Consequence in Therapy Response
Hipólito, A., Mendes, C., & Serpa, J. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-34025-4_16 · Cited by 10
Yu, L., Meng, Y., Zhang, J., Ma, L., Jiang, L., Zhang, Y., Yuan, M., Ren, A., Zhu, W., Li, S., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16026 · Cited by 10
Davoli, R., Braglia, S., Zappaterra, M., Redeghieri, C., Comella, M., & Zambonelli, P. (2014) · Livestock Science · doi:10.1016/j.livsci.2014.04.010 · Cited by 10
Zhao, Q., Kun, D., Hong, B., Deng, X., Guo, S. J., Tang, X., Yang, Y., Gong, K., Li, Q., Ye, L., et al. (2017) · Anticancer Research · doi:10.21873/anticanres.11832 · Cited by 10
Yin, B., Liu, Q., Zheng, Y., Gao, H., Lin, Y., & Zhao, Z. (2024) · Translational Oncology · doi:10.1016/j.tranon.2024.102056 · Cited by 9
Long noncoding RNAs regulating enzymatic reactions in cancer
Shin, C. H., Kim, K., Ho, C. W., Lee, J. W., Jo, M. J., Min, K., & Yoon, J. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01464-7 · Cited by 12
Over-Reduced State of Mitochondria as a Trigger of “β-Oxidation Shuttle” in Cancer Cells
Zhelev, Z., Sumiyoshi, A., Aoki, I., Lazarova, D., Vlaykova, T. I., Higashi, T., & Bakalova, R. (2022) · Cancers · doi:10.3390/cancers14040871 · Cited by 10
Wang, P., Peng, X., Hou, T., Xu, F., Zhou, H., Yu, Y., Qiu, M., Liu, Y., Zhao, Y., Guo, Z., et al. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.110199 · Cited by 9
Luan, Y., Chen, Z., Wang, X., Zhang, H., Tao, J., & Zhao, D. (2022) · Frontiers in Plant Science · doi:10.3389/fpls.2022.992529 · Cited by 9
Russo, G. I., Asmundo, M. G., Giudice, A. L., Trefiletti, G., Cimino, S., Ferro, M., Lombardo, R., Nunzio, C. D., Morgia, G., Piombino, E., et al. (2023) · Cancers · doi:10.3390/cancers15030948 · Cited by 11
Wang, Y., Sun, K., Liu, Y., Lu, Y., Feng, D., & Qi, H. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106165 · Cited by 8
Metadata
- Authors
- Migita, T., Narita, T., Nomura, K., Miyagi, E., Inazuka, F., Matsuura, M., Ushijima, M., Mashima, T., Seimiya, H., Satoh, Y., Okumura, S., Nakagawa, K., & Ishikawa, Y.
- Affiliations
- 1Pathology and Divisions of
- Zenyaku Kogyo (Japan) (JP)
- 2Cancer Genomics, The Cancer Institute,
- 3Bioinformatics Group, Genome Center,
- 4Division of Molecular Biotherapy, Cancer Chemotherapy Center,
- The Cancer Institute Hospital (JP)
- ORCID
- Venue
- Cancer Research
- Published
- 2008-10-15
- Volume
- 68
- Issue
- 20
- Pages
- 8547-8554
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2136765222
- Cited by
- 403
- References
- 45
- Citations by year
- 2026: 17 · 2025: 16 · 2024: 32 · 2023: 26 · 2022: 36 · 2021: 48 · 2020: 34 · 2019: 24 · 2018: 25 · 2017: 21 · 2016: 17 · 2015: 21 · 2014: 20 · 2013: 22 · 2012: 17
- FWCI
- 2.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- ATP citrate lyase, non-small cell lung cancer, lung adenocarcinoma, de novo lipogenesis, lipogenesis, Akt signaling, PI3K/Akt signaling, acetyl-CoA, cancer metabolism, RNA interference, insulin, palmitate, cell proliferation, prognostic factors, therapeutic target
- MeSH terms
- Adenocarcinoma, Animals, ATP Citrate (pro-S)-Lyase, Carcinoma, Non-Small-Cell Lung, Enzyme Activation, Humans, Lung Neoplasms, Phosphorylation, Prognosis, Cell Line, Tumor, Proto-Oncogene Proteins c-akt, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review